Strides Pharma

{
  "main_header": {
    "sid": 688428,
    "name": "Strides Pharma",
    "stock_name": "Strides Pharma",
    "full_name": "Strides Pharma Science Ltd",
    "name_url": "stocks-analysis/strides-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "962.95",
    "chg": -2.85,
    "chgp": "-0.3%",
    "dir": -1,
    "prev_price": "965.80",
    "mcapval": "8,571.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532531,
    "symbol": "STAR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE939A01011",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "2.19 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/strides-pharma-688428-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Strides Pharma Science Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/strides-pharma-science-ltd-is-rated-sell-3927394",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/StridesPharmaSc_mojoScore_3927394.png",
        "date": "2026-03-31 10:10:02",
        "description": "Strides Pharma Science Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 March 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 31 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Strides Pharma Declines 1.89%: Death Cross and Downgrade Signal Caution",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-declines-189-death-cross-and-downgrade-signal-caution-3922409",
        "imagepath": "",
        "date": "2026-03-28 17:12:45",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Mar 16:</strong> Stock opens at Rs.890.95, down 3.39% amid broader market gains</p>\n                    <p><strong>Mar 18:</strong> Strong rebound to Rs.905.10 (+3.29%) on increased volume</p>\n                    <p><strong>Mar 19:</strong> Formation of Death Cross signals potential bearish trend</p>\n                    <p><strong>Mar 20:</strong> Downgrade to Sell rating and mildly bearish technical shift</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.922.25</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div>..."
      },
      {
        "title": "Strides Pharma Science Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/strides-pharma-science-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3902383",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/StridesPharmaSc_mojoScore_3902383.png",
        "date": "2026-03-20 08:05:54",
        "description": "Strides Pharma Science Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 19 March 2026. This change is primarily driven by a deterioration in technical indicators, despite the company’s robust recent financial performance and attractive valuation metrics. The downgrade reflects a nuanced assessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals."
      },
      {
        "title": "Strides Pharma Science Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-faces-mildly-bearish-technical-shift-amid-mixed-momentum-signals-3902267",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/StridesPharmaSc_technicaldot_3902267.png",
        "date": "2026-03-20 08:02:18",
        "description": "Strides Pharma Science Ltd has experienced a subtle but notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish stance. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, reflecting a complex interplay of market forces impacting the small-cap pharmaceutical player."
      },
      {
        "title": "Strides Pharma Science Ltd Forms Death Cross, Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-forms-death-cross-signalling-potential-bearish-trend-3901381",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/StridesPharmaSc_dealthcross_3901381.png",
        "date": "2026-03-19 18:00:15",
        "description": "Strides Pharma Science Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium to long-term momentum and raising concerns about sustained weakness ahead."
      },
      {
        "title": "Strides Pharma Science Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/strides-pharma-science-ltd-is-rated-hold-by-marketsmojo-3896319",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/StridesPharmaSc_mojoScore_3896319.png",
        "date": "2026-03-17 10:10:17",
        "description": "Strides Pharma Science Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 05 March 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 17 March 2026, providing investors with the latest insights into the company's performance and outlook."
      },
      {
        "title": "Strides Pharma Gains 1.65%: Technical Shift and Valuation Drive Weekly Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-gains-165-technical-shift-and-valuation-drive-weekly-momentum-3891708",
        "imagepath": "",
        "date": "2026-03-14 17:09:25",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Mar:</strong> Stock opens at Rs.842.65, down 0.99% amid broad market weakness</p>\n                    <p><strong>4 Mar:</strong> Mildly bearish momentum confirmed as stock dips to Rs.831.80 (-1.29%)</p>\n                    <p><strong>5 Mar:</strong> MarketsMOJO upgrades rating to Hold; stock rallies 2.27% to Rs.850.65</p>\n                    <p><strong>6 Mar:</strong> Technical momentum shifts to mildly bullish; stock closes at Rs.865.05 (+1.69%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.842.65</div></div>\n                    <div class=\"stat-ite..."
      },
      {
        "title": "Strides Pharma Science Ltd Valuation Improves Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-valuation-improves-amid-strong-market-performance-3887999",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/StridesPharmaSc_valuationdot_3887999.png",
        "date": "2026-03-13 08:00:38",
        "description": "Strides Pharma Science Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating. This change reflects a recalibration of price-to-earnings and price-to-book value ratios, positioning the stock as a compelling option within the Pharmaceuticals & Biotechnology sector amid evolving market dynamics."
      },
      {
        "title": "Strides Pharma Science Ltd Upgraded to Hold on Improved Technicals and Valuation",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/strides-pharma-science-ltd-upgraded-to-hold-on-improved-technicals-and-valuation-3875276",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/StridesPharmaSc_mojoScore_3875276.png",
        "date": "2026-03-06 08:04:13",
        "description": "Strides Pharma Science Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators alongside robust quarterly financial results. The upgrade, effective from 5 March 2026, is underpinned by enhanced technical trends, attractive valuation metrics, and a strong financial performance in Q3 FY25-26, despite some lingering concerns over long-term fundamentals and promoter share pledging."
      }
    ],
    "total": 665,
    "sid": "688428",
    "stock_news_url": "https://www.marketsmojo.com/news/strides-pharma-science-688428"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2026",
      "details": "Intimation regarding closure of Trading Window for the quarter and year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "17-Mar-2026",
      "details": "Strides Strengthens its Africa Business with the Acquisition of Multiple Generic Brands from Sandoz",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of SEBI Listing Regulations",
      "datetime": "17-Mar-2026",
      "details": "This has reference to the Press Release issued by the Company today titled - Strides Strengthens its Africa Business with the Acquisition of Multiple Generic Brands from Sandoz. In this regard please find enclosed herewith disclosure under Regulation 30 of SEBI Listing Regulations.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Strides Pharma Science Ltd has declared <strong>40%</strong> dividend, ex-date: 22 Jul 25",
          "dt": "2025-07-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Strides Pharma Science Ltd is Rated Sell

2026-03-31 10:10:02

Strides Pharma Science Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 March 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 31 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Strides Pharma Declines 1.89%: Death Cross and Downgrade Signal Caution

2026-03-28 17:12:45

Key Events This Week

Mar 16: Stock opens at Rs.890.95, down 3.39% amid broader market gains

Mar 18: Strong rebound to Rs.905.10 (+3.29%) on increased volume

Mar 19: Formation of Death Cross signals potential bearish trend

Mar 20: Downgrade to Sell rating and mildly bearish technical shift

Week Open

Rs.922.25

Week Close

...

Read full news article

Strides Pharma Science Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-03-20 08:05:54

Strides Pharma Science Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 19 March 2026. This change is primarily driven by a deterioration in technical indicators, despite the company’s robust recent financial performance and attractive valuation metrics. The downgrade reflects a nuanced assessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals.

Read full news article

Strides Pharma Science Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum Signals

2026-03-20 08:02:18

Strides Pharma Science Ltd has experienced a subtle but notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish stance. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, reflecting a complex interplay of market forces impacting the small-cap pharmaceutical player.

Read full news article

Strides Pharma Science Ltd Forms Death Cross, Signalling Potential Bearish Trend

2026-03-19 18:00:15

Strides Pharma Science Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium to long-term momentum and raising concerns about sustained weakness ahead.

Read full news article

Strides Pharma Science Ltd is Rated Hold by MarketsMOJO

2026-03-17 10:10:17

Strides Pharma Science Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 05 March 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 17 March 2026, providing investors with the latest insights into the company's performance and outlook.

Read full news article

Strides Pharma Gains 1.65%: Technical Shift and Valuation Drive Weekly Momentum

2026-03-14 17:09:25

Key Events This Week

2 Mar: Stock opens at Rs.842.65, down 0.99% amid broad market weakness

4 Mar: Mildly bearish momentum confirmed as stock dips to Rs.831.80 (-1.29%)

5 Mar: MarketsMOJO upgrades rating to Hold; stock rallies 2.27% to Rs.850.65

6 Mar: Technical momentum shifts to mildly bullish; stock closes at Rs.865.05 (+1.69%)

Week Open

Rs.842.65

Read full news article

Strides Pharma Science Ltd Valuation Improves Amid Strong Market Performance

2026-03-13 08:00:38

Strides Pharma Science Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating. This change reflects a recalibration of price-to-earnings and price-to-book value ratios, positioning the stock as a compelling option within the Pharmaceuticals & Biotechnology sector amid evolving market dynamics.

Read full news article

Strides Pharma Science Ltd Upgraded to Hold on Improved Technicals and Valuation

2026-03-06 08:04:13

Strides Pharma Science Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators alongside robust quarterly financial results. The upgrade, effective from 5 March 2026, is underpinned by enhanced technical trends, attractive valuation metrics, and a strong financial performance in Q3 FY25-26, despite some lingering concerns over long-term fundamentals and promoter share pledging.

Read full news article

View All News